Serum pancreatic lipase immunoreactivity concentrations in dogs treated with potassium bromide and/or phenobarbital

Veterinary Therapeutics

Volumn 9, Issue 1, 2008, Pages 37-44

  Steiner, Jörg M ^a   Xenoulis, Panagiotis G ^a   Anderson, Joseph A ^a   Barr, A Catherine ^b   Williams, David A ^a,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY SYSTEM   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BROMIDE; PHENOBARBITAL; POTASSIUM BROMIDE; POTASSIUM DERIVATIVE; TRIACYLGLYCEROL LIPASE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CHEMICALLY INDUCED DISORDER; DOG; ENZYMOLOGY; IMMUNOASSAY; METABOLISM; METHODOLOGY; PANCREAS; PANCREATITIS;

ANIMALS; ANTICONVULSANTS; BROMIDES; DOGS; IMMUNOASSAY; LIPASE; PANCREAS; PANCREATITIS; PHENOBARBITAL; POTASSIUM COMPOUNDS;

CANIS FAMILIARIS;

EID: 42149170519     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Podell M, Fenner WR. Bromide therapy in refractory canine idiopathic epilepsy. J Vet Intern Med 1993;7: 318-327.
2. Locock C. Discussion of paper by Sieveking: analysis of 52 cases of epilepsy observed by the author. Med Times Gazette 1857;1:524-526.
3. Boenigk HE, Lorenz JH, Jürgens U. [Bromides - today still useful as antiepileptic substances?]. Nervenarzt 1985;56:579-582.
4. Ernst JP, Doose H, Baier WK. Bromides were effective in intractable epilepsy with generalized tonic-clonic seizures and onset in early childhood. Brain Dev 1988;10:385-388.
5. Schwartz-Porsche D, Jürgens U. Wirksamkeit von Bromid bei den therapieresistenten Epilepsien des Hundes. Tierärztl Prax 1991;19:395-401.
6. Dowling PM. Management of canine epilepsy with phenobarbital and potassium bromide. Can Vet J 1994;35:724-725.
7. March PA, Podell M, Sams RA. Pharmacokinetics and toxicity of bromide following high-dose oral potassium bromide administration in healthy beagles. J Vet Pharmacol Ther 2002;25:425-432.
8. Gaskill CL, Cribb AE. Pancreatitis associated with potassium bromide/ phenobarbital combination therapy in epileptic dogs. Can Vet J 2000;41:555-558.
9. Hess RS, Kass PH, Shofer FS, et al. Evaluation of risk factors for fatal acute pancreatitis in dogs. JAVMA 1999;214:46-51.
10. Williams DA, Steiner JM. Canine pancreatic disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 6th ed. St. Louis: Elsevier Saunders; 2005:1482-1488.
11. Frick TW, Speiser DE, Bimmler D, et al. Drug-induced acute pancreatitis: further criticism. Dig Dis 1993;11: 113-132.
12. Steiner JM, Teague SR, Williams DA. Development and analytic validation of an enzyme-linked immunosorbent assay for the measurement of canine pancreatic lipase immunoreactivity in serum. Can J Vet Res 2003;67:175-182.
13. Steiner JM, Broussard J, Mansfield CS, et al. Serum canine pancreatic lipase immunoreactivity (cPLI) concentrations in dogs with spontaneous pancreatitis [abstract]. J Vet Intern Med 2001;15:274.
14. Steiner JM, Newman SJ, Xenoulis PG, et al. Comparison of sensitivity of serum markets in dogs with macroscopic evidence of pancreatitis [abstract]. J Vet Intern Med 2007;21:614.
15. Steiner JM, Berridge BR, Wojcieszyn J, et al. Cellular immunolocalization of gastric and pancreatic lipase in various tissues obtained from dogs. Am J Vet Res 2002;63:722-727.
16. Steiner JM, Rutz GM, Williams DA. Serum lipase activities and pancreatic lipase immunoreactivity concentrations in dogs with exocrine pancreatic insufficiency. Am J Vet Res 2006;67:84-87.
17. Porterpan B, Zoran D, Steiner JM. Serial serum pancreatic lipase immunoreactivity concentrations in a dog with histologically confirmed pancreatitis. Vet Med 2006;101:170-176.
18. Steiner JM. Is it pancreatitis? Vet Med 2006;101:158-167.
19. Oguri K, Kurogi A, Yamabe K, et al. Purification of a phenobarbital-inducible UDP-glucuronosyltransferase isoform from dog liver which catalyzes morphine and testosterone glucuronidation. Arch Biochem Biophys 1996;325:159-166.
20. Ciaccio PJ, Halpert JR. Characterization of a phenobarbital-inducible dog liver cytochrome P450 structurally related to rat and human enzymes of the P450IIIA (steroid-inducible) gene subfamily. Arch Biocbem Biophys 1989;271:284-299.
21. Gamminger SR, Steiner JM, Ruaux CG, et al. Stability of serum canine pancreatic lipase (cPLI) concentration and comparison of cPLI concentrations in serum and plasma [abstract]. J Vet Intern Med 2002; 16:382.
22. Steiner JM, et al: Unpublished data, College Station, TX, 2007.
23. Steiner JM, Lees GE, Willard MD, et al. Serum canine pancreatic lipase immunoreactivity (cPLI) concentration is not altered by oral prednisone administration [abstract]. J Vet Intern Med 2003;17:444.